HPV16 E6 Variants in Cervical Cancer
Author Information
Author(s): Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sällström J, Wilander E
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
The study investigates the distribution of HPV16 E6 oncoprotein variants in different types of cervical neoplastic lesions.
Conclusion
The HPV16 E6 variant L83V is prevalent in preinvasive and invasive cervical lesions, but its predominance in squamous carcinomas is not observed in adenocarcinomas.
Supporting Evidence
- The HPV16 E6 variant L83V was present in 40% of HCIN lesions.
- 54% of invasive adenocarcinomas contained the L83V variant.
- 81% of invasive squamous carcinomas had the L83V variant.
- The difference in prevalence between HCIN and squamous carcinomas was statistically significant.
- The difference in prevalence between HCIN and invasive adenocarcinomas was not statistically significant.
Takeaway
This study looked at how a specific part of a virus (HPV16) behaves in different types of cervical cancer, finding that it acts differently in squamous versus glandular cancers.
Methodology
The study analyzed HPV16-positive cervical adenocarcinomas using PCR-SSCP to identify the L83V mutation.
Participant Demographics
Swedish women with cervical adenocarcinomas and other cervical lesions.
Statistical Information
P-Value
P = 0.604
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website